Copertina

POP‐REFINE: A Comprehensive Framework for Evaluating and Optimizing Representativeness in Clinical Trials

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Corey M. Benedum, Somnath Sarkar, Selen Bozkurt, Ruma Bhagat, Nicole Richie, Bea Lavery, Sandra D. Griffith
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Clinical Pharmacology & Therapeutics
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Operationalizing Decentralized Clinical Trials: Technology Insights from the Trials@Home RADIAL Proof‐of‐Concept Trial
di: Sten Hanke, et al.
Pubblicazione: (2025)

Progress, Pitfalls, and Impact of AI‐Driven Clinical Trials
di: Dominika Wilczok, et al.
Pubblicazione: (2024)

Home Is Where the Research Is: The Promise of Decentralized Clinical Trials
di: Sarah A. Holstein
Pubblicazione: (2025)

Registered Clinical Trials of Ayahuasca and DMT : A Scoping Review
di: Tijana Stojanović, et al.
Pubblicazione: (2026)

Assessing Correlation between Surrogate Endpoints and Overall Survival for Oncology Clinical Trials
di: Guotao Chu, et al.
Pubblicazione: (2025)

Capturing Synergy Holistically in Psychedelic Clinical Trials: Assessing Processes in Addition to Outcomes
di: Terence H.W. Ching, et al.
Pubblicazione: (2024)

Impact of COVID‐19 on the Conduct and Design of Clinical Trials: IQ Consortium Perspective
di: Mohamed‐Eslam F. Mohamed, et al.
Pubblicazione: (2024)

Extended Model‐Informed Drug Development: Beyond Clinical Trials and Regulatory Approval
di: Mohamed A. Kamal, et al.
Pubblicazione: (2024)

Insights into Clinical Trials for Drugs Targeting MASLD: Progress, Challenges, and Future Directions
di: Yu Wu, et al.
Pubblicazione: (2025)

Tepid Uptake of Digital Health Technologies in Clinical Trials by Pharmaceutical and Medical Device Firms
di: Caroline Marra, et al.
Pubblicazione: (2024)

How Much More Efficient Are Adaptive Platform Trials Than Multiple Stand‐Alone Trials? A Comprehensive Simulation Study for Streamlining Drug Development During a Pandemic
di: Masanao Sasaki, et al.
Pubblicazione: (2024)

Tracing Digital Therapeutics Research Across Medical Specialties: Evidence from ClinicalTrials.gov
di: Lars Masanneck, et al.
Pubblicazione: (2024)

From the Randomized AMBORA Trial to Clinical Practice: Comparison of Medication Errors in Oral Antitumor Therapy
di: Lisa Cuba, et al.
Pubblicazione: (2024)

Impact of Model‐Informed Drug Development on Drug Development Cycle Times and Clinical Trial Cost
di: Vaishali Sahasrabudhe, et al.
Pubblicazione: (2025)

The Role for Clinical Translational Pharmacology in Advancing Pharmacoequity
di: Sonya Tang Girdwood, et al.
Pubblicazione: (2025)

Bringing Trial Activities to Participants—The Trials@Home RADIAL Proof‐of‐Concept Trial Investigating Decentralization of Trials
di: Mira G.P. Zuidgeest, et al.
Pubblicazione: (2025)

A Framework for Assessing the Viability of External Control for a Single‐Arm Trial
di: Victor A. Kiri
Pubblicazione: (2026)

Biomarkers of Drug‐Induced Kidney Injury: Use in Clinical Trials and Recent Examples of Impact on Drug Development
di: Tanja S. Zabka, et al.
Pubblicazione: (2025)

Regulatory Pathways for Qualification and Acceptance of Digital Health Technology‐Derived Clinical Trial Endpoints: Considerations for Sponsors
di: Jessie P. Bakker, et al.
Pubblicazione: (2024)

Analysis by Age, Sex, Race, and Ethnicity of Participants in Clinical Trials Supporting Recently Approved Novel Therapies
di: Neali H. Lucas, et al.
Pubblicazione: (2025)

All that Glitters Is not Gold: Type‐I Error Controlled Variable Selection from Clinical Trial Data
di: Manuela R. Zimmermann, et al.
Pubblicazione: (2024)

Optimizing Early Clinical Investigations in Cancer Immunotherapy: The Translational Journey of RG6292, a Novel, Selective Treg‐Depleting Antibody
di: Sara Belli, et al.
Pubblicazione: (2024)

Model‐Informed Precision Dosing Using Machine Learning for Levothyroxine in General Practice: Development, Validation and Clinical Simulation Trial
di: Jules M. Janssen Daalen, et al.
Pubblicazione: (2024)

Implementing Pharmacogenomics Clinical Decision Support: A Comprehensive Tutorial on how to Integrate the Epic Genomics Module
di: Bradley T. Hall, et al.
Pubblicazione: (2025)

Clinical Benefit, Trials, and Regulatory Approval of Oncology Indications Under Multiple Expedited Programs for Drug Marketing in China, 2018–2024
di: Jie Zhang, et al.
Pubblicazione: (2025)

Is a Clinical Trial With a Non‐Bioequivalent Batch Necessary? The Critical Role of Intrasubject Variability in Olaparib Formulation Bridging by PBPK
di: Jin Dong, et al.
Pubblicazione: (2026)

Quantitative Systems Pharmacology‐Based Digital Twins Approach Supplements Clinical Trial Data for Enzyme Replacement Therapies in Pompe Disease
di: Chanchala Kaddi, et al.
Pubblicazione: (2024)

Impact of Antihypertensive Treatment on Outcomes of Adjuvant Bevacizumab for Ovarian Cancer ( IATRO ), Results from a Nationwide Emulated Clinical Trial
di: Floriane Jochum, et al.
Pubblicazione: (2025)

Community Partnerships in Clinical Research: A Framework for Sustainability and Resilience
di: Shayna R. Killam, et al.
Pubblicazione: (2026)

Summary Report of a Public Workshop: Case Studies of Multi‐Regional Clinical Trial Incorporating Concept of the ICH E17 Guideline
di: Nobuko Matsushima, et al.
Pubblicazione: (2024)

Country Contribution to Investigators of Pivotal Clinical Trials and Their Primary Publications of New Drugs Approved by the US Food and Drug Administration, 2012–2021
di: Yoona Choi, et al.
Pubblicazione: (2025)

Regulatory Interactions and Learnings— RADIAL the Trials@Home Proof‐of‐Concept Trial on Decentralization
di: Helga Gardarsdottir, et al.
Pubblicazione: (2025)

The Future of Clinical Translational Pharmacology
di: Matthew L. Rizk, et al.
Pubblicazione: (2026)

Infrequent Resolution of Vaso‐Occlusive Crises in Routine Clinical Care Among Patients Mimicking the Exa‐Cel Trial Population: A Cohort Study of Medicaid Enrollees
di: Mufaddal Mahesri, et al.
Pubblicazione: (2024)

Questioning the Design of Non‐Inferiority Trials: The Strange Case for Therapeutic Drug Monitoring Absence in Phase III Trials
di: Florian Lemaitre, et al.
Pubblicazione: (2024)

Optimizing Clinical Translation of Bispecific T‐cell Engagers through Context Unification with a Quantitative Systems Pharmacology Model
di: Xiaozhi Liao, et al.
Pubblicazione: (2024)

Regulatory Issues of Platform Trials: Learnings from EU‐PEARL
di: Quynh Lan Nguyen, et al.
Pubblicazione: (2024)

A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical Practice
di: Teresa T. Ho, et al.
Pubblicazione: (2025)

A Phase I Trial of the Pharmacokinetic Interaction Between Cannabidiol and Tacrolimus
di: Gerald C. So, et al.
Pubblicazione: (2024)

Clinical Evidence 2030
di: Peter Arlett, et al.
Pubblicazione: (2025)